Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04188288 · ClinicalTrials.gov registry record · NA
Neurofeedback in Individuals With Substance Use Disorders
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04188288 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 12 participants.
The verdict
NCT04188288, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The aim of this study is to train individuals with opioid use disorder to control their brain activity in a way that has been associated with their symptoms. Participants in the experimental group will be given direct feedback regarding their brain activity while they are undergoing functional magnetic resonance imaging (fMRI) scanning, and will try to learn to control their brain activity during these feedback sessions. A separate group of participants will be given a control form of feedback that we do not believe can have clinical benefits. Our primary hypothesis is that the neurofeedback training will reduce opioid use and clinical features of opioid use disorder more than the control feedback.
Interventions
- DEVICE fMRI
- DEVICE Experimental feedback
- DEVICE Control feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2023-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04188288
The ClinicalTrials.gov registry entry for NCT04188288 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which fMRI is the first listed.
NCT04188288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04188288 about?
NCT04188288 is a clinical study titled "Neurofeedback in Individuals With Substance Use Disorders". The aim of this study is to train individuals with opioid use disorder to control their brain activity in a way that has been associated with their symptoms. Participants in the experimental group will be given direct feedback regarding their brain activity while they are undergoing functional magne...
What is the current status of trial NCT04188288?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2021-07-01. Estimated completion is 2023-03-15.
What interventions are being tested in trial NCT04188288?
The interventions under investigation include: fMRI (DEVICE), Experimental feedback (DEVICE), Control feedback (DEVICE).
Who is sponsoring clinical trial NCT04188288?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.